Drugs / HY209GEL
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06024499 Comparator | Mar 2024 → Apr 2026 | atopic eczema, scalp dermatosis | Shaperon | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HY209GEL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06024499 ↗ |